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Mutations in genes encoding for GABAA receptor subunits is a well-established cause
of genetic generalized epilepsy. GABA neurotransmission is implicated in several
developmental processes including neurite outgrowth and synapse formation. Alteration
in excitatory/inhibitory synaptic activities plays a critical role in epilepsy, thus here we
investigated whether mutations in α1 subunit of GABAA receptor may affect dendritic
spine and GABAergic bouton formation. In particular, we examined the effects of
three mutations of the GABRA1 gene (D219N, A322D and K353delins18X) that were
found in a cohort of French Canadian families with genetic generalized epilepsy. We
used a novel single-cell genetic approach, by preparing cortical organotypic cultures
from GABRA1flox/flox mice and simultaneously inactivating endogenous GABRA1 and
transfecting mutant α1 subunits in single glutamatergic pyramidal cells and basket
GABAergic interneurons by biolistic transfection. We found that GABRA1−/− GABAergic
cells showed reduced innervation field, which was rescued by co-expressing α1-A322D
and α1-WT but not α1-D219N. We further found that the expression of the most severe
GABRA1 missense mutation (α1-A322D) induced a striking increase of spine density
in pyramidal cells along with an increase in the number of mushroom-like spines. In
addition, α1-A322D expression in GABAergic cells slightly increased perisomatic bouton
density, whereas other mutations did not alter bouton formation. All together, these
results suggest that the effects of different GABAAR mutations on GABAergic bouton
and dendritic spine formation are specific to the mutation and cannot be always explained
by a simple loss-of-function gene model. The use of single cell genetic manipulation in
organotypic cultures may provide a better understanding of the specific and distinct neural
circuit alterations caused by different GABAA receptor subunit mutations and will help
define the pathophysiology of genetic generalized epilepsy syndromes.
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INTRODUCTION
Genetic factors play a key role in the development and severity of
genetic generalized epilepsy (GGE). Epilepsy-causing mutations
have been identified in several GABAA receptor (GABAAR) sub-
units, including α1, β3, γ2, and δ subunits (Baulac et al., 2001;
Wallace et al., 2001; Cossette et al., 2002; Harkin et al., 2002;
Kananura et al., 2002; Dibbens et al., 2004, 2009; Audenaert et al.,
2006; Maljevic et al., 2006; Sun et al., 2008; Tanaka et al., 2008;
Lachance-Touchette et al., 2010, 2011; Shi et al., 2010; Klassen
et al., 2011; Carvill et al., 2013, 2014; Epi et al., 2013; Tian
et al., 2013; Hancili et al., 2014; Ishii et al., 2014; Johnston et al.,
2014). GABAARs are ligand-gated ion channels that are perme-
able to chloride and bicarbonate anions and mediate most of
cortical inhibitory neurotransmission. Their molecular structure
comprises of a heteropentameric protein complex assembled
from 19 different subunits (α1–6, β1–3, γ1–3, δ, ε, π, θ, and
ρ1–3). Although there is the potential for a high variability of
combinations, the α1β2γ2 is the most abundant and represents
approximately 60% of all GABAARs in adult brain (Sieghart and
Sperk, 2002). Mutations in the GABRA1 gene are linked to a
spectrum of endophenotypes of GGE syndromes as well as more
severe forms of epilepsy associated with intellectual disability
(Carvill et al., 2014). We previously reported D219N, A322D,
K353delins18X mutations in families with autosomal dominant
genetic generalized epilepsy (Cossette et al., 2002; Lachance-
Touchette et al., 2011). Whether these mutations cause protein
inactivation and thus loss of function is still unclear. Deletion of
α1 in mice produced EEG spike-wave discharges and absence-like
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seizures (Arain et al., 2012). This mousemodel recapitulates some
of the epilepsy phenotypes that were reported in human carriers
of GABRA1mutations (Cossette et al., 2002; Maljevic et al., 2006;
Klassen et al., 2011; Lachance-Touchette et al., 2011). In vitro
investigations in heterologous cells demonstrated that GABRA1
mutants could affect mRNA transcript stability, cell surface
GABAAR composition and channel gating properties (Cossette
et al., 2002; Gallagher et al., 2004, 2007; Krampfl et al., 2005;
Maljevic et al., 2006; Lachance-Touchette et al., 2011; Carvill et al.,
2014). By expressing wild type or mutant α1 in heterologous cells,
we previously showed that A322D and K353delins18X muta-
tions reduced GABA-evoked currents amplitude by impairing
α1β2γ2 receptor surface expression due to endoplasmic reticu-
lum retention (Krampfl et al., 2005; Lachance-Touchette et al.,
2011). In addition, two GABRA1 mutations (A322D, D219N)
exhibited altered gating kinetic properties (Lachance-Touchette
et al., 2011). Further, studies in cultured neurons revealed that
α1-A322D mutation altered the kinetics and the amplitude of
miniature inhibitory postsynaptic currents (mIPSCs) in pyrami-
dal neurons (Ding et al., 2010). These data support the hypothesis
that reduced inhibition underlies network hyperexcitability in
GGE associated with GABAAR mutations.
On the other hand, GABAAR mutations may also alter specific
developmental processes. Alterations in the number and strength
of inhibitory and excitatory synapses are thought to contribute to
epilepsy (Bernard, 2012). In addition, GABA transmission have
been shown to play a key role during brain development, influ-
encing virtually all developmental steps from neurogenesis to
the establishment of neuronal connectivity (Gaiarsa and Porcher,
2013; Kilb et al., 2013). Focusing in particular on synaptogene-
sis, recent studies demonstrated in organotypic cortical slices that
endogenous GABA regulates axonal branching and synapse for-
mation of cortical basket cells—a prominent class of GABAergic
neurons—through the activation of GABAA and GABAB recep-
tors (Chattopadhyaya et al., 2007; Baho and Di Cristo, 2012;
Wu et al., 2012). GABAergic transmission can also play a criti-
cal role in excitatory synapse development. In pyramidal neurons
of the cerebral cortices, excitatory synaptic inputs are made on
small dendritic protrusions, called dendritic spines. Hayama et al.
(2013) showed that dendritic spine shrinkage and elimination can
be promoted either by uncaging of a caged GABA compound
that mimics IPSCs or by tonic application of a GABAA agonist,
muscimol. Whether and how GABRA1mutations affect dendritic
spines and GABAergic bouton formation, thus contributing to
the epilepsy phenotype has not been so far examined.
So far, the vast majority of mutations in GABAAR subunits
causing Human epilepsy are associated with loss-of-function,
when assessing gating properties of the GABA-evoked currents in
vitro (Macdonald and Kang, 2009). However, review of functional
studies on GABRAmutations in heterologous cell system revealed
controversial findings between different groups (reviewed in
Cossette et al., 2012). For example, for long time no consensus
was reached regarding the impact ofGABRG2missensemutations
on GABA currents amplitude or kinetics as well as cell surface
expression by using heterologous cell culture. Only the genera-
tion of a mouse model harboring the γ2 point mutation (R82Q)
dissipated all these ambiguities (Tan et al., 2007). The emergence
of massive gene-sequencing studies will generate an enormous
amount of data, on the other hand developing mouse knock-
in models for each new GABRA mutations is unrealistic, both
because it is time consuming and far too expansive.
Here, we propose of using single cell genetic manipulation to
investigate the effects of different mutations of GABAA α1 sub-
unit on both dendritic spine and GABAergic bouton formation in
cortical organotypic slices, which maintain the three dimensional
structure of the brain tissue and the tight spatial relationships
between different cell types. In particular, we analyzed the den-
sity and morphology of pyramidal cell dendritic spines, which
are the preferential postsynaptic site of glutamatergic synapses.
We also examined the axon morphology and bouton density of
basket cells, which are the most prominent type of GABAergic
interneurons in the cortex.
MATERIALS AND METHODS
MICE
Funder mice B6.129(FVB)-Gabra1tm1Geh/J, first described in
Vicini et al. (2001), were kindly gifted by Dr. Rudolph (McLean
Hospital, HarvardMedical School) (Vicini et al., 2001). They were
bred to establish a colony in the animal facility at the Centre
de recherche du Centre hospitalier de l’Université de Montréal
(CRCHUM). All mice were housed under standard pathogen-
free conditions in a 12 h light/dark cycle with ad libitum access
to sterilized laboratory chow diet. Animals were treated in accor-
dance with Canadian Council for Animal Care and protocols were
approved by the Animal Care Committee of the CRCHUM and of
CHU Ste-Justine Research Center. B6.129(FVB)-Gabra1tm1Geh/J
mice were previously produced in amixed background. The back-
ground was characterized with a microsatellite panel consisting of
110 markers spread across the genome at about 15 cM intervals
and was confirmed to be 99.08% congenic to C57BL/6J back-
ground (Charles River, NY). B6.129(FVB)-Gabra1tm1Geh/J mice
possess three loxP sites on both sides of the α1 exon encoding an
essential transmembrane domain of GABAA receptor.
DNA CONSTRUCTS
PG67-GFP was generated by subcloning of a 10 kb region of Gad1
gene promoter by gap repair in front of the GFP coding region
in pEGFP (Clontech) as previously described (Chattopadhyaya
et al., 2004). We subcloned CRE, GABRA1-A322D, GABRA1-
D219N, GABRA1-K353delins18X constructs (Cossette et al.,
2002; Lachance-Touchette et al., 2011) in PG67 vector by using
restriction site Pme1 via sequence and ligation–independent
cloning method (SLIC) (Li and Elledge, 2007). All constructs
were sequenced to confirm the presence of the mutations and to
exclude any other variants that may have been introduced during
PCR amplification.
SLICE CULTURE AND BIOLISTIC TRANSFECTION
Slice culture preparation was done as described by Stoppini
et al. (1991). Postnatal day 4 or 5 (P4 or P5) mouse pups were
decapitated, and brains were rapidly removed and immersed in
ice-cold culture medium (containing DMEM, 20% horse serum,
1mM glutamine, 13mM glucose, 1mM CaCl2, 2mM MgSO4,
0.5μm/ml insulin, 30mM HEPES, 5mM NaHCO3, and 0.001%
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ascorbic acid). Coronal brain slices of the occipital cortex, 400μm
thick, were cut with a Chopper (Stoelting, Wood Dale, IL).
Slices were then placed on transparent Millicell membrane inserts
(Millipore, Bedford, MA), usually three slices/insert, in 30mm
Petri dishes containing 0.75ml of culture medium. Finally, the
slices were incubated in a humidified incubator at 34◦C with
a 5% CO2-enriched atmosphere and the medium was changed
three times per week. All procedures were performed under ster-
ile conditions. Constructs to be transfected were incorporated
into “bullets” that were made using 1.6μm gold particles coated
with a total of ∼60μg of the DNA(s) of interest. These bullets
were used to biolistically transfect slices by Gene gun (Bio-Rad,
Hercules, CA) at high pressure (180ψ), and the transfected slices
were incubated for 8 days in vitro under the same conditions as
described above, before imaging. For each experimental group,
cortical slices were prepared from at least three mice. On average
6–7 neurons were transfected per cortical organotypic slice. The
majority of neurons labeled by this promoter were parvalbumin-
positive basket cells (as described in Chattopadhyaya et al., 2004,
2007), while a minority (∼10%) were pyramidal cells. Pyramidal
cells were recognized by the complexity of their dendritic arbor,
including an apical dendrite, and the presence of numerous
dendritic spines.
IMAGING AND SPINE ANALYSIS OF PYRAMIDAL CELLS
Pyramidal neurons were imaged using a Leica confocal micro-
scope SPE (63X glycerol immersion objective; NA 1.3). At least 6
labeled pyramidal neurons, characterized by the presence of a well
defined apical dendrite, were randomly selected from cortical lay-
ers 2/3 and 5. Image stacks of basal dendrites were acquired with a
z-step of 0.5μm and then reconstructed in 3D with Neurolucida
(MicroBrightField) software. Cortical pyramidal cells from at
least four animals were used for each experimental condi-
tion. Dendritic length, total spine density, spine morphology
and spine length were quantified using NeuroExplorer software
(MicroBrightField). Mushroom spines were defined as spine with
a neck and bearing a head, which was at least twice as large as the
neck. Thin spines were defined as dendritic protrusions shorter
than 5μm and lacking a clearly defined head. All quantifications
were done blind to the treatment.
ANALYSIS OF BASKET CELL INNERVATION
We quantified two aspects of basket cell axon innervation field
(1) the extent of perisomatic innervation around single neu-
ronal somata (terminal branching and perisomatic GFP-positive
bouton density) and (2) the percentage of potentially inner-
vated cells in the field (percentage of innervation). We have
previously shown that the vast majority of GFP-labeled boutons
in our experimental condition most likely represent presynap-
tic terminals, by localization of pre- and post-synaptic markers
and electron microscopy (Chattopadhyaya et al., 2004, 2007;
Wu et al., 2012). For each experimental group, we took care
to acquire an equal number of basket cells localized in layers
2/3 and 5/6 of the cortex. We acquired at least two confocal
stacks of each basket cell axon arbor in the first 150μm from
the basket cell soma using a 63X glycerol objective (NA 1.3,
Leica) and a Leica TCS SPE confocal microscope. The typical
confocal stack size was 116.4 × 116.4μm with an average depth
of 40–70μm and a z-step of 1μm. Analysis of basket cell peri-
somatic innervation and bouton size was performed essentially
as described by Chattopadhyaya et al. (2013). Briefly, in our
Three-Dimensional Sholl analysis, Sholl spheres with a 1μm
increment from the center of a pyramidal soma were used to
quantify basket axon terminal branch complexity and bouton
density around the pyramidal cell soma. Axon branch complex-
ity around a single pyramidal cell soma was quantified by the
average number of intersections between basket cell axons and
the Sholl spheres in the first 9μm from the center of the pyra-
midal cell soma. We choose 9μm as the limiting radius for a
Sholl sphere because it approximates the average pyramidal cell
soma diameter measured from pyramidal neurons immunos-
tained with NeuN antibody. Between 10 and 15 pyramidal neu-
rons were analyzed for each basket cell. Bouton density around
each pyramidal cell soma was measured within the same set of
Sholl spheres and averaged among pyramidal neurons for each
condition. Only pyramidal cell somata with Sholl spheres, which
intersected the basket cell axon in the first 9μm from the cen-
ter of their soma, were taken for analysis. Using this approach,
we obtained an unbiased estimate of the number of presumptive
boutons on individual labeled pyramidal cell soma. The percent-
age of neuron somata innervated by a basket cell was defined in a
confocal stack by the number of NeuN-positive cells contacted by
at least one GFP-positive-bouton divided by the total number of
NeuN-positive cells. This was repeated over all the fields of each
basket axon and the results were averaged (Chattopadhyaya et al.,
2013).
All data were first averaged per basket cell, statistical analysis
was then done using the number of basket cells as n.
STATISTICAL ANALYSIS
Differences between groups were assessed with One-Way ANOVA
followed by post-hoc Holm–Sidak test for normally distributed
data or One-Way ANOVA followed by post-hoc Kruskal–Wallis
test for not-normally distributed data. The cells analyzed derived
from at least three different sets of experiments. Data are
expressed in term of mean ± standard error of mean (SEM).
RESULTS
GABRA1 is broadly expressed in the nervous system and
GABAAR-mediated signaling plays multiple roles during devel-
opment (Rossignol, 2011). In order to examine how differ-
ent GABRA1 mutants may affects the formation of dendritic
spine and GABAergic bouton formation, we used a transgenic
mouse carrying a conditional allele of GABRA1 (Vicini et al.,
2001), which allows cell-type and developmental-stage restricted
knockdown of GABRA1 synthesis. In this floxed-GABRA1mouse
(GABRA1flox/flox), Cre-mediated recombination results in exci-
sion of exon 8, causing a shift in reading frame and premature
termination of translation.
To inhibit GABRA1 expression in isolated pyramidal neu-
rons and GABAergic basket cells and simultaneously label their
dendritic and axonal arbors at high resolution, we used a previ-
ously characterized promoter region PG67 (Chattopadhyaya et al.,
2004) to express either Cre recombinase together with GFP
Frontiers in Cellular Neuroscience www.frontiersin.org October 2014 | Volume 8 | Article 317 | 3
Lachance-Touchette et al. Mutant GABAA receptors and development
FIGURE 1 | Schematic of the experimental approach.
(PG67-GFP/Cre) or GFP alone (PG67-GFP) in cortical organotypic
cultures of GABRA1flox/flox mice (Figure 1). For pyramidal neu-
rons, we focussed our analysis on dendritic spines, because
dendritic spine alterations have been observed both in experi-
mental animal models of epilepsy (Wong, 2005; Ma et al., 2013)
and in human epilepsy patients (Multani et al., 1994; Isokawa,
2000). GABAergic basket cells (BCs), which represent about 40%
of all cortical GABAergic cells in rodents, form synapses onto
the somata and proximal dendrites of excitatory pyramidal cells.
Because of the perisomatic localization and strength of their
synapses, BCs strongly control the firing output of pyramidal
cells and are thought to be important contributors to the main-
tenance of the overall excitation/inhibition balance in the cortex
(Haider and McCormick, 2009). Further, BCs could act as a gate
to prevent runaway excitation, which underlies the propagation
of epileptiform activity (Trevelyan et al., 2007). Previous studies
have shown that the basic features of dendritic spine forma-
tion and of the maturation of perisomatic innervation by BCs
onto pyramidal cells are retained in cortical organotypic cul-
tures (Dunaevsky et al., 1999; Chattopadhyaya et al., 2004; Di
Cristo et al., 2004). We genetically manipulated pyramidal cells
and BCs between the third and fourth postnatal week during
which a significant and stereotyped maturation of BCs periso-
matic innervation occurs (Chattopadhyaya et al., 2004, 2007; Di
Cristo et al., 2007). Pyramidal cells from GABRA1flox/flox cultures
transfected with PG67-GFP/Cre (referred here on as GABRA1−/−
cells) from equivalent postnatal day 16 (EP16, P4 + 12 days
in vitro) to EP24 showed no significant alterations in the overall
spine density and morphology compared to age-matched control
transfected only with PG67-GFP (Figures 2G–H; Supplementary
Figure 1; total spine densityGABRA1+/+ vs.GABRA1−/−; 0.63±
0.04 vs. 0.71 ± 0.05 spine/μm; p > 0.05). GABRA1−/− BCs
showed a significant reduction in the number of contacted
target cells (Figure 3H; GABRA1+/+ vs. GABRA1−/−; 61 ±
2% vs. 41 ± 3%; p < 0.05). In turn, the perisomatic inner-
vations they formed around contacted neurons did not differ
from those formed by control age-matched BCs, in term of
bouton density or terminal branching (Figure 3F; GABRA1+/+
vs. GABRA1−/−; 9.1 ± 0.5 vs. 9.6 ± 0.7 boutons/soma; p >
0.05). The axon density and average internode axon length
were also not significantly different between these two groups
(Supplementary Figure 2), thus suggesting that knockdown of
GABRA1 in this developmental time window did not affect overall
axon growth.
To explore whether and how specific GABRA1 mutants asso-
ciated with GGE affect pyramidal cell spine and BCs GABAergic
bouton formation, we inactivated the endogenous GABRA1 alle-
les and simultaneously re-introduced either GABRA1WT/WTor
each of the GABRA1 mutant separately in single pyramidal and
BCs from EP16–24. We choose this approach because global
GABRA1 manipulations may alter the excitation/inhibition bal-
ance of the whole slice, therefore making it difficult to distinguish
between specific effects of distinct GABRA1 mutants and unspe-
cific, generalized effects of altered neuronal activity. In our exper-
imental model, GABRA1 was deleted only in sparse neurons in
an otherwise wild-type background. It is therefore unlikely that
the overall excitation levels in the slices was altered. A second
critical advantage of our single-cell labeling/genetic manipulation
approach is that we could visualize, reconstruct and quantify at
high-resolution the dendritic and axonal arbors of single neurons
with their putative boutons.
GABRA1WT/WT expression in GABRA1−/− pyramidal cells
did not alter overall spine density (Figure 2G; GABRA1+/+ vs.
GABRA1WT/WT ; 0.63 ± 0.04 vs. 0.74 ± 0.05 spine/μm p >
0.05), although we observed a slight increase in the density of
thin spines (Figure 2H; GABRA1+/+ vs. GABRA1WT/WT ; 0.02 ±
0.005 vs. 0.09 ± 0.02 thin spines/μm; p < 0.001). Importantly,
GABRA1WT/WT expression rescued the number of target cells
contacted by each GABRA1−/− BC (Figure 3H; GABRA1+/+ vs.
GABRA1WT/WT ; 61 ± 2% vs. 59 ± 4%; p > 0.05 and Figure 3H;
GABRA1−/− vs. GABRA1WT/WT ; 41 ± 3% vs. 59 ± 4%; p <
0.001) suggesting that biolistic transfection of GABRA1WT/WT
under the PG67 promoter can drive the expression of enough
protein to rescue GABRA1 deficits in single cells.
Interestingly, we found that α1-A322D expression in
GABRA−/− pyramidal cells specifically and significantly
increased both total spine density (Figure 2G; GABRA1+/+
vs. GABRA1AD/AD; 0.63 ± 0.04 vs. 0.9 ± 0.1 spines/μm;
p < 0.05) and the proportion of mushroom-like spines on
pyramidal cells basal dendrites (Figure 2H; Supplementary
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FIGURE 2 | α1-A322D expression induces a significant increase in the
number and maturation of dendritic spines in cortical pyramidal cells.
(A1–A3) Confocal images showing pyramidal cells transfected with GFP
(green) alone (control, GABRA1+/+ cells) or (B1–B3) GFP and CRE
(GABRA1−/−) to knockdown endogenous α1 subunits, or GFP-CRE and either
one of the wild-type or mutants α1 (C1–F3) to investigate the effects of
different α1 mutants on spine density and morphology, in organotypic
cultures. (A3–F3) High-magnification images of dendrites from pyramidal cells
in A2–F2. White arrowheads indicates mushroom spines, yellow arrowhead
indicate a thin spine. (G,H) α1-A322Dmutant pyramidal cells show significantly
increased density of total (G) and mushroom-like spines (H) compared to
control age-matched pyramidal cells (One-Way ANOVA; ∗p < 0.05). α1-WT
expression induces a significant increase in thin-like spines (H, One-Way
ANOVA; ∗p < 0.05). GFP n = 7; GFP-CRE n = 9; GFP-CRE-WT n = 7;
GFP-CRE-A322D n = 7; GFP-CRE-D219N n = 6; GFP-CRE-K353delins18X
n = 7 pyramidal cells. Scale bars: A1–F1, 50μm; A2–F2, 10μm; A3–F3, 5μm.
Figure 1; GABRA1+/+ vs. GABRA1AD/AD; 0.48 ± 0.05 vs. 0.8 ±
0.1 mushroom spines/μm; p < 0.05). As dendritic spines are
the preferential site for glutamatergic synapse formation and
mushroom spines in particular tend to show larger EPSCs
compared to other spine types (Lee et al., 2012), these data
suggest that α1-A322D expression may increase both the number
and strength of excitatory synapses. In parallel, we found that
α1-A322D expression in GABRA1−/− BCs rescued the loss of
innervated targets caused by GABRA1 deletion (Figure 3H;
GABRA1+/+ vs. GABRA1AD/AD; 61 ± 2% vs. 51 ± 2%; p > 0.05)
and further increased the number of GABAergic boutons formed
by BCs onto target cell somata compared to age-matched controls
(Figure 3F; GABRA1+/+ vs. GABRA1AD/AD; 9.1 ± 0.5 vs. 13 ± 1
boutons/soma; p < 0.05), suggesting that α1-A322D expression
can increase the formation of GABAergic boutons.
Finally, we found that the expression of the other mutants, α1-
D219N or α1-K353delins18X, had no effects on spine density and
morphology in GABRA1−/− pyramidal cells. On the other hand,
α1-D219N expression failed to rescue the loss of innervated tar-
geted cells caused by GABRA1 deletion (Figure 3H; GABRA1+/+
vs. GABRA1DN/DN ; 61 ± 2 vs. 46 ± 5%; p < 0.001) and showed
a trend toward reduced bouton density, which however did not
reach significance (Figure 3F; GABRA1+/+ vs. GABRA1DN/DN ;
9.1 ± 0.5 vs. 7.5 ± 0.8 boutons/soma; p > 0.05). In summary,
our data show a remarkably GABRA1 mutant-specific effects on
both dendritic spine and GABAergic bouton formation.
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FIGURE 3 | α1-A322D expression induces a significant increase in
boutons formed by GABAergic cortical basket cells. (A–E) Low
(A1–E1) and high magnification (A2–E2) confocal images showing basket
cells transfected with GFP (green) alone (A, GABRA1+/+cells) or GFP and
CRE (B, GABRA1−/− cells), or GFP-CRE and either one of the wild-type or
mutants α1 subunits (C–E). Basket cells form terminal axon branching
bearing numerous presynaptic boutons around NeuN (red)-positive somata
(arrowheads). A3–E3 are high-magnification images from boxed areas in
A2–E2. (F) GABRA1−/− basket cells transfected with α1-A322D show
significant increase in bouton density (F). Local branching (G) does not differ
across the groups. (H) GABRA1−/− basket cells contact less pyramidal
somata compared to age-matched basket cells. This deficit is rescued by the
expressions of α1-wild-type or α1-A322D but not of α1-D219N (One-Way
ANOVA; ∗p < 0.05). GFP n = 6; GFP-CRE, n = 6; GFP-CRE-WT, n = 6;
GFP-CRE-A322D, n = 6; GFP-CRE-D219N, n = 4 basket cells. Scale bars:
A1–E1, 50μm; A2–E2, 10μm; A3–E3, 5μm.
DISCUSSION
All together, our data show for the first time that different
GABRA1mutations associated with familial autosomal dominant
GGE can affect dendritic spine and GABAergic bouton formation
in a mutation-specific manner. Interestingly, GABRA1 deletion
in single pyramidal neurons did not affect their dendritic spine
density or morphology, likely due to the compensatory action
of other α1 subunits of GABAAR. Consistently, α2 and α3 pro-
teins were expressed at higher-level in the cerebral cortex of
GABRA1-KO mice (Bosman et al., 2005; Zeller et al., 2008). In
the same mouse model, global deletion of the α1 subunit trig-
gered an increase in the density of postsynaptic sites expressing
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α3 subunit in the molecular layer of the cerebellum, which has
been interpreted as a reorganization of cerebellar networks (Kralic
et al., 2006). On the other hand, GABRA1 deletion reduced
the extent of BC innervation field in a cell-autonomous fash-
ion (Figure 3), indicating that compensatory expression of other
alpha subunits may not occur in GABAergic cells or that changes
in inhibitory inputs caused by the presence of GABAAR lacking
the α1 subunit may alter BC development. In fact, it has been
shown that the maturation of the innervation field of GABAergic
BCs is exquisitely dependent on neuron excitability and GABA
release (Chattopadhyaya et al., 2007; Baho and Di Cristo, 2012;
Wu et al., 2012). Consistent with this hypothesis, Purkinje cells
from GABRA1−/− mice lacked spontaneous and evoked IPSCs
(Fritschy and Panzanelli, 2006). In addition, stellate cell synapses
on Purkinje cells dendrites were reduced by 75% in the same
mouse model (Fritschy and Panzanelli, 2006). Unexpectedly, the
expression of α1-WT in a knock-out background (GABRA1−/−
pyramidal neurons) increased the formation of thin spines, which
are generally thought to represent immature/new synapses. One
possibility is that the overexpression of α1-WT causes excess
inhibition, which in turn promotes the formation of new exci-
tatory synapses (Queenan et al., 2012). Quantitative analysis of
inhibitory and excitatory inputs onto transfected neurons will
be necessary to clarify this issue and will be the focus on future
studies.
Surprisingly, we found that different α1 mutants have very
different impacts on the development of GABAergic boutons
and dendritic spines. The GABRA1 mutant that showed the
most dramatic effects on both pyramidal cell spines and basket
cell innervation field was α1-A322D. This observation is consis-
tent with previous electrophysiological studies showing that this
mutation has more severe effect in vitro on the gating proper-
ties of the GABA-evoked currents, compared to other GABRA1
missense mutations (Macdonald et al., 2010; Lachance-Touchette
et al., 2011). One possibility is that α1-A322D may act as domi-
nant negative. Using cell cultures, Ding et al. (2010) showed that
α1-A322D reduced the overall surface expression of GABAAR by
associating with the wild type subunits within the endoplasmic
reticulum and preventing them from trafficking to the cell surface
(Ding et al., 2010; Lachance-Touchette et al., 2011). Reduction in
cell surface expression of GABAAR resulted in decreased postsy-
naptic inhibition (Ding et al., 2010), which may in turn facilitate
long-term potentiation (LTP) of excitatory synapses (Carlson
et al., 2002). One of the main effects of LTP is the increase in
AMPA-receptor density at postsynaptic sites on dendritic spines
(Liu et al., 2005; Whissell et al., 2013), which correlate with the
presence of more mature mushroom spines characterized by large
heads (Luscher et al., 2000), consistently to what we observed
(Figure 2). Similarly, reduction of inhibition onto BCs could pro-
mote GABA release and, subsequently, formation of GABAergic
boutons (Chattopadhyaya et al., 2007; Baho and Di Cristo, 2012).
Therefore, these results suggest that altered excitatory/inhibitory
synaptic balance may be partially responsible for the increased
excitability of cortical networks in human carriers of α1-A322D.
Interestingly, α1-D219N expression in GABRA1−/− BC was
unable to rescue the deficits in their innervation field, while it
did not affect dendritic spine density. Our prior works showed
that GABAARs containing α1-D219Nwere trafficked to themem-
brane and that mutation altered GABAA receptor gating kinet-
ics. In particular, GABAARs containing α1-D219N have slower
desensitization rates and faster off-kinetics compared to wild-
type receptors (Lachance-Touchette et al., 2011). It is therefore
possible that reduced inhibition may be partially responsible
for both altered development of GABAergic cells and increased
excitability of neuronal circuits in human carriers of α1-D219N.
Finally, the expression of α1-K353delins18X did not affect any
of the developmental events we analyzed. We have previously
reported that this frameshift mutation altered the downstream
amino acid sequence and resulted in the introduction of a prema-
ture translation–termination codon (PTC) (Lachance-Touchette
et al., 2011). The premature translation termination is likely to
cause mRNA degradation by a process called nonsense-mediated
mRNA decay (Baker and Parker, 2004), thereby explaining why
expression of α1-K353delins18X did not affect the phenotype of
GABRA1−/− neurons.
All together, our data suggest that a “loss-of-function” model
may not always explain the effects of GABRA1mutations on den-
dritic spines and GABAergic bouton formation. For example,
reduced inhibition is most often mentioned as a cause of epilep-
tic syndromes. Here, our data suggest that α1-A322Dmay instead
increase the number of dendritic spines, which are the preferen-
tial site of excitatory synapse formation, an event that may result
in higher cortical excitation. These potential effects on develop-
ing neuronal networks need to be further explored by recording
miniature inhibitory (mIPSCs) and excitatory (mEPSCs) postsy-
naptic currents in transfected neurons.
With the advance in the technology of large-scale multiplex
sequencing or next-generation sequencing (NGS), it is now pos-
sible to obtain the sequence of the whole exome (WES) and even
the whole genome (WGS) for a given individual. These method-
ological approaches are very powerful and are already opening
new frontiers of genomics research. However, by sequencing
many more genomes, we will need in vitro models to determine
the functional biological role of all new variants that we will find.
The use of heterelogs models such as HEK cells and xenopus
oocytes may not be the best systems to test the impact of muta-
tions in GABAAR subunits. For example, despite a large number
of studies, the functional alterations caused by missenses muta-
tions identified in GABRG2 in epileptic patients are still not well
understood. In fact, there is no consensus about the effect of the
mutations R82Q, P83S, R177G, and K328M on the GABA cur-
rents amplitude (Baulac et al., 2001; Wallace et al., 2001; Bianchi
et al., 2002; Bowser et al., 2002; Kang andMacdonald, 2004; Hales
et al., 2005; Audenaert et al., 2006; Kang et al., 2006; Eugene
et al., 2007; Frugier et al., 2007; Goldschen-Ohm et al., 2010;
Lachance-Touchette et al., 2011; Huang et al., 2014; Todd et al.,
2014). As another example, it is still debated whether β3-P11S,
β3-G32R, and γ2-P83S altered surface expression of the GABAAR
or of the subunit itself (Tanaka et al., 2008; Delahanty et al.,
2011; Lachance-Touchette et al., 2011; Gurba et al., 2012). In
addition, the exclusive use of non-neuronal cells will not answer
the question on how biophysical alterations in mutated receptor
properties may alter brain development and ultimately lead to
hyperexcitable networks. Here, we suggest that organotypic slice
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cultures may provide an accessible system for investigating the
specific effects of GABA receptor mutants on neuronal develop-
ment. Moreover, in contrast to what occur in dissociated neuronal
cultures, organotypic slice cultures retain complex 3-dimensional
interactions between different cell types as they occur in vivo.
Therefore, we believe that the single cell genetic manipulation
described here is a novel tool to understand how GABAA receptor
mutants disrupt neuronal circuit formation and will help define
the pathophysiology of genetic epilepsy syndromes.
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